Clinical Trial Update: Glucose Control Through a Bihormonal Artificial Pancreas in Patients After Total Pancreatectomy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a bihormonal artificial pancreas to control glucose after total pancreatectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neoplasms
• Total Pancreatectomy
• Type 3c Diabetes

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Pancreatic Neoplasms, Type 3c Diabetes | Phase 3 | Status: UNKNOWN